$0.03-0.02 (-42.08%)
Aditxt, Inc.
Aditxt, Inc. in the Healthcare sector is trading at $0.03 with a market capitalization of $23,580. The stock is currently near its 52-week low of $0.03, remaining 100.0% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 0 is oversold, raising the odds of a near-term bounce. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on o...
Aditxt announced a definitive business combination agreement valuing its subsidiary, Ignite Proteomics, at $150 million.
US stocks look set to open higher in Wednesday's trading session as investors parse Tuesday's mixed
EPWK Holdings Ltd. 21,353,609 0.0834